The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr

How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference

Cash-pay strips with good accuracy and co-pay programs to save money

With Roche’s support, mySugr will expand to more countries and will even begin offering a new package with unlimited test strips and diabetes coaching through German...

New Dexcom and Fitbit collaboration to put CGM data on the wrist, a convenience win and the third smartwatch platform for Fitbit. What else might they develop?

A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...

New Livongo Family Care Plan available without a prescription or insurance

Easy-to-use Bydureon pen cuts down on the hassle of once-weekly injections by offering convenient mixing, a hidden needle, and more​

Dr. Shreela Sharma’s advice for eating well, moving more, and making goals stick in the New Year

Why a good night of sleep transforms Adam Brown's diabetes the next day

A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide

Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017

Leading scientists discuss areas of growth ranging from behavior to artificial intelligence at The diaTribe Foundation’s “Solvable Problems” event in Lisbon

The hardest chapter to write: my story

Express Scripts recently announced the launch of Inside Rx, a discount prescription program with savings ranging from 16% to nearly 80% for insulin and other diabetes...

Q&A with Bike Beyond riders on what got them through a 10-week cross country bike trip

Continuously delivers GLP-1 agonist for 3-6 months; FDA decision is expected by the end of 2017

Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...

New apps and software updates from mySugr, Insulia, One Drop, as well as food and weight loss apps

Recall applies to sets manufactured before April 2017; Medtronic is replacing old sets that have a risk of insulin over-delivery